skip to main content

Type 2 diabetes with ASCVD — RCPSC IM MCQ

Instant feedback + full explanation. One question, done properly.

HardEndocrinologyType 2 diabetes with ASCVDRCPSC IM

A 64-year-old woman with type 2 diabetes and established coronary artery disease has A1c 7.8 percent on metformin. eGFR is 62 mL/min/1.73 m2, urine albumin-creatinine ratio is 18 mg/mmol, and BMI is 33 kg/m2. She has no history of pancreatitis. What is the most appropriate management?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: CAdd an SGLT2 inhibitor or GLP-1 receptor agonist with cardiovascular benefit

In type 2 diabetes with established cardiovascular disease, glucose-lowering therapy should include an agent with proven cardiovascular benefit, such as an SGLT2 inhibitor or GLP-1 receptor agonist when appropriate.

Reference: Diabetes Canada clinical practice guidelines